Dapagliflozin reduced cisplatin resistance in hepatoblastoma cells [114], and canagliflozin sensitized HepG2 cells to irradiation, concomitantly with the inhibition of the PI3K/AKT/mToR pathway and β-catenin [115] (Figure 2). The gene discussed is AKT1; the disease is hepatoblastoma.